Clinical Trial Update: Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating imatinib mesylate with intravitreal ranibizumab for choroidal neovascularization due to age-related macular degeneration has been withd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization

Drugs mentioned

• Imatinib mesylate (Imatinib)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: Vitreous -Retina- Macula Consultants of New York | Conditions: Choroidal Neovascularization | Phase 1 | Status: WITHDRAWN